Home

Sight Sciences, Inc. - Common Stock (SGHT)

4.6900
+1.2400 (35.94%)
NASDAQ · Last Trade: Oct 19th, 8:29 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Top movers in Friday's sessionchartmill.com
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.
Via Chartmill · October 17, 2025
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · October 17, 2025
Top stock movements in today's session.chartmill.com
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · October 17, 2025
Earnings Scheduled For August 7, 2025benzinga.com
Via Benzinga · August 7, 2025
Earnings Scheduled For May 8, 2025benzinga.com
Via Benzinga · May 8, 2025
Breaking Down Sight Sciences: 6 Analysts Share Their Viewsbenzinga.com
Via Benzinga · March 4, 2025
What 6 Analyst Ratings Have To Say About Sight Sciencesbenzinga.com
Via Benzinga · February 6, 2025
Expert Outlook: Sight Sciences Through The Eyes Of 5 Analystsbenzinga.com
Via Benzinga · January 15, 2025
Which stocks are gapping on Friday?chartmill.com
Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps.
Via Chartmill · October 17, 2025
UnitedHealthcare Adds Sight Sciences OMNI System To Covered Glaucoma Surgery Proceduresbenzinga.com
UnitedHealthcare's new policy covers implant-free glaucoma surgeries like OMNI, supporting treatment for mild to moderate open-angle glaucoma and cataracts.
Via Benzinga · September 9, 2025
What 4 Analyst Ratings Have To Say About Sight Sciencesbenzinga.com
Via Benzinga · August 21, 2025
The Analyst Verdict: Sight Sciences In The Eyes Of 4 Expertsbenzinga.com
Via Benzinga · July 15, 2025
These stocks are moving in today's pre-market sessionchartmill.com
Wondering what's happening in Monday's pre-market session? Find an overview in this article.
Via Chartmill · April 28, 2025
Where Sight Sciences Stands With Analystsbenzinga.com
Via Benzinga · December 11, 2024
Sight Sciences: Q4 Earnings Insightsbenzinga.com
Via Benzinga · March 7, 2024
These stocks are moving in today's pre-market sessionchartmill.com
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · April 2, 2025
Earnings Scheduled For March 5, 2025benzinga.com
Via Benzinga · March 5, 2025
Sight Sciences's Earnings: A Previewbenzinga.com
Via Benzinga · March 6, 2024
Top 3 Health Care Stocks You'll Regret Missing In Novemberbenzinga.com
Via Benzinga · November 5, 2024
SGHT Stock Earnings: Sight Sciences Misses EPS, Beats Revenue for Q1 2024investorplace.com
SGHT stock results show that Sight Sciences missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 2, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesdayinvestorplace.com
Pre-market stock movers are a hot topic this morning as we check out all of the biggest news worth reading about on Wednesday morning!
Via InvestorPlace · April 3, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · April 2, 2024
SGHT Stock Earnings: Sight Sciences Beats EPS, Misses Revenue for Q4 2023investorplace.com
SGHT stock results show that Sight Sciences beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 7, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · January 24, 2024
Earnings Scheduled For March 7, 2024benzinga.com
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via Benzinga · March 7, 2024